title: The course of retinal vasculitis.
abstract: OBJECTIVE
  To determine if characteristics of retinal vasculitis correlate with ocular complications, or the response to different lines of treatment.
  
  
  METHODS
  We performed a computerised database analysis of 56 patients evaluated for uveitis at the Casey Eye Institute from September 1985 until May 2010. All patients had non-infectious retinal vasculitis and at least 1 year of follow-up.
  
  
  RESULTS
  Although occlusive vasculitis was rare, retinal neovascularisation occurred much more commonly in the occlusive vasculitis subgroup than among the non-occlusive vasculitis subgroup (p<0.01). Epiretinal membrane (ERM) was found more commonly in the retinal vasculitis patients who presented with cotton wool spots and intraretinal haemorrhage compared to retinal vasculitis patients who presented with sheathing noted on clinical examination (p<0.01). Smoking was significantly related to vision loss. Age at presentation below 40 years correlated with therapy beyond oral corticosteroids
  
  
  CONCLUSIONS
  The heterogeneity of retinal vasculitis should be considered in providing prognostic information. Neovascularisation occurs more commonly in occlusive retinal vasculitis, and ERM is diagnosed more frequently in conjunction with cotton wool spots and intraretinal haemorrhage rather than just vascular sheathing. Cigarette use predicts visual loss and patients who are relatively young often receive treatment beyond oral corticosteroids.
authors: Department of Ophthalmology, Oregon Health & Science University, Portland, Oregon, USA.
authors: Amro
authors: A
authors: Ali
authors: Department of Ophthalmology, Oregon Health & Science University, Portland, Oregon, USA Department of Public Health and Preventive Medicine, Oregon Health & Science University, Portland, Oregon, USA.
authors: Jennifer H
authors: JH
authors: Ku
authors: Department of Ophthalmology, Oregon Health & Science University, Portland, Oregon, USA Department of Public Health and Preventive Medicine, Oregon Health & Science University, Portland, Oregon, USA Portland Veterans Affairs Medical Center, Portland, Oregon, USA.
authors: Eric B
authors: EB
authors: Suhler
authors: Department of Public Health and Preventive Medicine, Oregon Health & Science University, Portland, Oregon, USA.
authors: Dongseok
authors: D
authors: Choi
authors: Department of Ophthalmology, Oregon Health & Science University, Portland, Oregon, USA Department of Medicine, Oregon Health & Science University, Portland, Oregon, USA Devers Eye Institute, Legacy Health Systems, Portland, Oregon, USA.
authors: James T
authors: JT
authors: Rosenbaum
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D019773:Epiretinal Membrane / Q000175:diagnosis* / Q000188:drug therapy; D005260:Female; D005451:Fluorescein Angiography; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis; D012166:Retinal Hemorrhage / Q000175:diagnosis* / Q000188:drug therapy; D015861:Retinal Neovascularization / Q000175:diagnosis* / Q000188:drug therapy; D031300:Retinal Vasculitis / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects; D014786:Vision Disorders / Q000209:etiology; D014792:Visual Acuity
chemical_list: D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D011241:Prednisone
keywords: Epidemiology; Retina; Treatment Medical; Vision